BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 10959441)

  • 1. Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM
    Adv Pediatr; 2000; 47():79-115. PubMed ID: 10959441
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!
    Farrell PM; Lai HJ; Li Z; Kosorok MR; Laxova A; Green CG; Collins J; Hoffman G; Laessig R; Rock MJ; Splaingard ML
    J Pediatr; 2005 Sep; 147(3 Suppl):S30-6. PubMed ID: 16202779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data.
    Lai HJ; Cheng Y; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S57-63. PubMed ID: 16202784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for cystic fibrosis: an opportunity to improve care and outcomes.
    Campbell PW; White TB
    J Pediatr; 2005 Sep; 147(3 Suppl):S2-5. PubMed ID: 16202776
    [No Abstract]   [Full Text] [Related]  

  • 5. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa.
    Baussano I; Tardivo I; Bellezza-Fontana R; Forneris MP; Lezo A; Anfossi L; Castello M; Aleksandar V; Bignamini E
    Pediatrics; 2006 Sep; 118(3):888-95. PubMed ID: 16950978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.
    Comeau AM; Accurso FJ; White TB; Campbell PW; Hoffman G; Parad RB; Wilfond BS; Rosenfeld M; Sontag MK; Massie J; Farrell PM; O'Sullivan BP;
    Pediatrics; 2007 Feb; 119(2):e495-518. PubMed ID: 17272609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.
    Lee DS; Rosenberg MA; Peterson A; Makholm L; Hoffman G; Laessig RH; Farrell PM
    J Pediatr; 2003 Jun; 142(6):617-23. PubMed ID: 12838188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.
    Koscik RL; Lai HJ; Laxova A; Zaremba KM; Kosorok MR; Douglas JA; Rock MJ; Splaingard ML; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S51-6. PubMed ID: 16202783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and neonatal screening of cystic fibrosis].
    Roussey M; Deneuville E; Dabadie A
    Rev Prat; 2003 Jan; 53(2):135-40. PubMed ID: 12664843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neonatal screening for cystic fibrosis].
    Marchac V
    Soins Pediatr Pueric; 2004 Jun; (218):21-2. PubMed ID: 15327070
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe.
    Dankert-Roelse JE; Mérelle ME
    J Pediatr; 2005 Sep; 147(3 Suppl):S15-20. PubMed ID: 16202775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group.
    Massie J; Clements B;
    Pediatr Pulmonol; 2005 May; 39(5):440-6. PubMed ID: 15704202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot newborn screening project for cystic fibrosis in the Czech Republic: defining role of the delay in its symptomatic diagnosis and influence of ultrasound-based prenatal diagnosis on the incidence of the disease.
    Balascaková M; Holubová A; Skalická V; Zemková D; Kracmar P; Gonsorcíkova L; Camajová J; Piskácková T; Lebl J; Drevínek P; Gregor V; Vávrová V; Votava F; Macek M
    J Cyst Fibros; 2009 May; 8(3):224-7. PubMed ID: 19208501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical issues in newborn screening research: lessons from the Wisconsin cystic fibrosis trial.
    Taylor HA; Wilfond BS
    J Pediatr; 2004 Sep; 145(3):292-6. PubMed ID: 15343177
    [No Abstract]   [Full Text] [Related]  

  • 15. [National program for neonatal screening for cystic fibrosis: implementation and preliminary results].
    Navarro J; Grosskopf C; Vidailhet M; Briard ML; Farriaux JP
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S56-60. PubMed ID: 12592165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in new South Wales.
    McKay KO; Waters DL; Gaskin KJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S47-50. PubMed ID: 16202782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis: refining the approach to newborn screening.
    Wilcken B
    J Pediatr; 2009 Nov; 155(5):605-6. PubMed ID: 19840611
    [No Abstract]   [Full Text] [Related]  

  • 19. Scots launch cystic fibrosis screening for newborns.
    Pract Midwife; 2003 Apr; 6(4):10. PubMed ID: 12715497
    [No Abstract]   [Full Text] [Related]  

  • 20. [Screening tests for cystic fibrosis in the neonate].
    Shalev H; Weizman Z
    Harefuah; 1992 Apr; 122(8):508-11. PubMed ID: 1398320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.